News
Bohemia Interactive has brought the Arma experience to PlayStation today, and has launched Arma Reforger on PS5 as a surprise. You can grab it on the PlayStation Store by following the Arma ...
Last month Arcus reported top -line phase 2 results with the TIGIT drug that it said warranted taking it forward into a phase 3 programme, but so far there's no word from Gilead on a buy-in.
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes ...
The G7 ambassadors to Ukraine have welcomed the adoption of a law reforming the National Agency of Ukraine for Finding, Tracing and Management of Assets Derived from Corruption and Other Crimes (ARMA) ...
Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Business Central CEO Simon Arcus told Ryan Bridge things will probably still fluctuate in coming years. He says there are often moments where things seem to improve, then sink back again.
A lot of Arma 3 players are encountering occasional ‘Referenced Memory‘ errors after the game crashes. This error seems to occur in various different forms (with ...
Arcus Biosciences, Inc. (RCUS) earnings report: revenue, EPS, surprise, history, news and analysis. Skip to content Home page Seeking Alpha - Power to Investors ...
Are you eager to dive into a comprehensive Mobile Legends: Adventure tier list? Then you're in the right place. This article will cover the best characters in the game and give you everything that you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results